July 10, 2017
Stories this photo appears in:
Dendreon Pharmaceuticals LLC expanded its senior management with three new hires and two promotions.
Company Now in OC, Targets U.S., China Growth
Dendreon Pharmaceuticals LLC received the Food and Drug Administration’s thumbs-up for its prostate-cancer therapy Provenge in 2010, and analysts projected $4.3 billion in annual sales by 2020, yet it was a blockbuster that failed to premiere.